Moneycontrol PRO

business

Aurobindo Pharma has target of Rs 1626: Kapadia

Aurobindo Pharma has target of Rs 1626, says Ranjit Kapadia, Vice President-Institutional Research, HDFC Securities.

first published: Jan 3, 2011 07:36 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347